Vascular Access Devices Market - Global Forecast to 2030

Table of Content

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.3 STUDY SCOPE 42
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 42
1.3.2 INCLUSIONS & EXCLUSIONS 43
1.3.3 YEARS CONSIDERED 44
1.3.4 CURRENCY CONSIDERED 44
1.4 STAKEHOLDERS 45
1.5 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
2.1.1 SECONDARY DATA 46
2.1.1.1 Objectives of secondary research 47
2.1.1.2 Key secondary sources 47
2.1.1.3 Key data from secondary sources 48
2.1.2 PRIMARY DATA 48
2.1.2.1 Key primary sources 49
2.1.2.2 Key objectives of primary research 49
2.1.2.3 Key data from primary sources 50
2.1.2.4 Key industry insights 51
2.2 MARKET SIZE ESTIMATION 52
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 52
2.2.2 TOP-DOWN APPROACH 53
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 53
2.2.4 DEMAND-SIDE ANALYSIS 53
2.3 GROWTH FORECAST 54
2.4 DATA TRIANGULATION 57
2.5 MARKET RANKING ANALYSIS 58
2.6 STUDY ASSUMPTIONS 58
2.7 RESEARCH LIMITATIONS 58
2.7.1 METHODOLOGY-RELATED LIMITATIONS 58
2.7.2 SCOPE-RELATED LIMITATIONS 59
2.8 RISK ANALYSIS 59
3 EXECUTIVE SUMMARY 60
?
4 PREMIUM INSIGHTS 68
4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW 68
4.2 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER
AND COUNTRY, 2023 69
4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET, 2023 70
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET, 2024–2030 (USD MILLION) 71
4.5 VASCULAR ACCESS DEVICES MARKET: EMERGING VS. DEVELOPED MARKETS,
2024 VS. 2030 (USD MILLION) 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
5.2.1 DRIVERS 73
5.2.1.1 Growing prevalence of lifestyle diseases 73
5.2.1.2 Increasing popularity of chemotherapy procedures
among cancer patients 73
5.2.1.3 Rising use of vascular access devices among pediatric patients 73
5.2.2 RESTRAINTS 74
5.2.2.1 High cost of installation and maintenance of vascular access devices 74
5.2.2.2 Rising product recalls and failures 74
5.2.3 OPPORTUNITIES 75
5.2.3.1 Technological advancements 75
5.2.3.2 Increasing number of hospitals and expanding patient pool 75
5.2.4 CHALLENGES 76
5.2.4.1 Shortage of skilled healthcare professionals 76
5.2.4.2 Risks associated with use of vascular access devices 76
5.3 TECHNOLOGY ANALYSIS 77
5.3.1 KEY TECHNOLOGIES 77
5.3.1.1 Imaging and navigation technologies 77
5.3.1.2 Catheter securement and stabilization technologies 77
5.3.2 COMPLEMENTARY TECHNOLOGIES 77
5.3.2.1 AI and ML 77
5.3.3 ADJACENT TECHNOLOGIES 78
5.3.3.1 Infection control technologies 78
5.4 INDUSTRY TRENDS 78
5.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES 78
5.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS 78
5.5 VALUE CHAIN ANALYSIS 79
5.6 ECOSYSTEM ANALYSIS 80
5.6.1 ROLE IN ECOSYSTEM 81
5.7 SUPPLY CHAIN ANALYSIS 82
?
5.8 TRADE ANALYSIS 83
5.8.1 IMPORT DATA FOR HS CODE 901839 83
5.8.2 EXPORT DATA FOR HS CODE 901839 84
5.9 PORTER’S FIVE FORCES ANALYSIS 85
5.9.1 THREAT OF NEW ENTRANTS 87
5.9.2 THREAT OF SUBSTITUTES 87
5.9.3 BARGAINING POWER OF BUYERS 87
5.9.4 BARGAINING POWER OF SUPPLIERS 87
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 87
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 88
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
5.10.2 KEY BUYING CRITERIA 89
5.11 REGULATORY ANALYSIS 89
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
5.11.2 REGULATORY FRAMEWORK 92
5.11.2.1 North America 92
5.11.2.1.1 US 92
5.11.2.1.2 Canada 92
5.11.2.2 Europe 93
5.11.2.3 Asia Pacific 93
5.11.2.4 Latin America 93
5.11.2.5 Middle East & Africa 94
5.12 PATENT ANALYSIS 94
5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 94
5.13 PRICING ANALYSIS 96
5.13.1 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,
BY KEY PLAYER, 2021–2023 96
5.13.2 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,
BY REGION, 2021–2023 97
5.14 KEY CONFERENCES & EVENTS, 2025–2026 98
5.15 ADJACENT MARKET ANALYSIS 99
5.15.1 VASCULAR CLOSURE DEVICES MARKET 99
5.16 UNMET NEEDS/END-USER EXPECTATIONS 100
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 101
5.18 INVESTMENT & FUNDING SCENARIO 101
5.19 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET 102
6 VASCULAR ACCESS DEVICES MARKET, BY TYPE 104
6.1 INTRODUCTION 105
6.2 CENTRAL VENOUS ACCESS DEVICES 105
6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS 108
6.2.1.1 Better durability and increased clinical utility for extended treatment plans to drive segment 108
6.2.2 TUNNELED CATHETERS 110
6.2.2.1 Lower risk of infection and superior longevity to support
segment growth 110
6.2.3 NON-TUNNELED CATHETERS 112
6.2.3.1 Non-tunneled catheters to be used in critical cases with limited peripheral access 112
6.2.4 IMPLANTABLE PORTS 114
6.2.4.1 Implantable conventional ports 117
6.2.4.1.1 Ability to provide reliable venous access with minimal maintenance to spur adoption 117
6.2.4.2 Implantable power injectable ports 119
6.2.4.2.1 Ability to accommodate high-flow fluids and increased demand for chemotherapy to propel market growth 119
6.3 PERIPHERAL VASCULAR ACCESS DEVICES 121
6.3.1 PERIPHERAL VENOUS ACCESS DEVICES 124
6.3.1.1 Peripheral intravenous catheters 127
6.3.1.1.1 Cost-effectiveness, ease of placement, and compatibility with different treatments to augment segment growth 127
6.3.1.2 Midline catheters 129
6.3.1.2.1 Ability to provide reliable medium-term intravenous access from one to four weeks to aid segment growth 129
6.3.1.3 Butterfly/Winged steel needles 131
6.3.1.3.1 Precision and comfort in short-term venous access procedures to drive segment 131
6.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES 133
6.3.2.1 Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth 133
6.4 ACCESSORIES 135
6.4.1 NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET 135
6.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES 137
6.5.1 CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES 137
7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 140
7.1 INTRODUCTION 141
7.2 INTRAVENOUS ROUTE OF INSERTION 141
7.2.1 RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH 141
7.3 SUBCUTANEOUS ROUTE OF INSERTION 143
7.3.1 REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH 143
?
7.4 INTRAOSSEOUS ROUTE OF INSERTION 145
7.4.1 NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES
TO FUEL UPTAKE 145
8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 148
8.1 INTRODUCTION 149
8.2 DRUG ADMINISTRATION 150
8.2.1 CHEMOTHERAPY 152
8.2.1.1 Increased incidence of cancer and advancements in oncology care to drive segment 152
8.2.2 OTHER DRUG ADMINISTRATION 154
8.3 FLUID & NUTRITION ADMINISTRATION 156
8.3.1 INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH 156
8.4 BLOOD TRANSFUSION 158
8.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH 158
8.5 DIAGNOSTICS & TESTING 160
8.5.1 INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH 160
9 VASCULAR ACCESS DEVICES MARKET, BY END USER 163
9.1 INTRODUCTION 164
9.2 HOSPITALS 164
9.2.1 PUBLIC HOSPITALS 165
9.2.1.1 Increasing demand for affordable healthcare services in emerging economies to drive segment 165
9.2.2 PRIVATE HOSPITALS 167
9.2.2.1 Rising demand for advanced healthcare services and high-quality treatment options to drive market 167
9.3 CLINICS & AMBULATORY CARE CENTERS 169
9.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH 169
9.4 OTHER END USERS 171
10 VASCULAR ACCESS DEVICES MARKET, BY REGION 174
10.1 INTRODUCTION 175
10.2 NORTH AMERICA 178
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 178
10.2.2 US 187
10.2.2.1 US to dominate North American vascular access devices market during forecast period 187
10.2.3 CANADA 194
10.2.3.1 Rising cancer prevalence and advanced research initiatives to
propel market growth 194
10.3 EUROPE 202
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 202
10.3.2 GERMANY 210
10.3.2.1 Rising obesity rates and growing geriatric population to augment market growth 210
10.3.3 UK 217
10.3.3.1 Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures 217
10.3.4 FRANCE 224
10.3.4.1 Presence of vascular access device manufacturers and technological advancements to fuel market growth 224
10.3.5 ITALY 231
10.3.5.1 Strong government healthcare policies to boost market growth 231
10.3.6 SPAIN 238
10.3.6.1 Growing geriatric population and rising incidence of chronic diseases to fuel market growth 238
10.3.7 REST OF EUROPE 244
10.4 ASIA PACIFIC 252
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 252
10.4.2 CHINA 261
10.4.2.1 Advanced healthcare infrastructure and high geriatric population to support market growth 261
10.4.3 INDIA 269
10.4.3.1 Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth 269
10.4.4 JAPAN 276
10.4.4.1 Increased geriatric population and high prevalence of cancer to drive market 276
10.4.5 AUSTRALIA 283
10.4.5.1 Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth 283
10.4.6 SOUTH KOREA 290
10.4.6.1 Rising burden of chronic diseases and increasing aged population to boost market growth 290
10.4.7 REST OF ASIA PACIFIC 298
10.5 LATIN AMERICA 305
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 305
10.5.2 BRAZIL 313
10.5.2.1 Growing cancer burden and rising need for long-term treatment for chronic patients to drive market 313
10.5.3 MEXICO 320
10.5.3.1 Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices 320
10.5.4 REST OF LATIN AMERICA 327
?
10.6 MIDDLE EAST & AFRICA 334
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 334
10.6.2 GCC COUNTRIES 342
10.6.2.1 Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth 342
10.6.3 REST OF MIDDLE EAST & AFRICA 349
11 COMPETITIVE LANDSCAPE 357
11.1 INTRODUCTION 357
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 357
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET 357
11.3 REVENUE ANALYSIS, 2019–2023 359
11.4 MARKET SHARE ANALYSIS, 2023 360
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 362
11.5.1 STARS 362
11.5.2 EMERGING LEADERS 362
11.5.3 PERVASIVE PLAYERS 362
11.5.4 PARTICIPANTS 363
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 364
11.5.5.1 Company footprint 364
11.5.5.2 Region footprint 365
11.5.5.3 Type footprint 366
11.5.5.4 Route of insertion footprint 367
11.5.5.5 Application footprint 368
11.5.5.6 End-user footprint 369
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 370
11.6.1 PROGRESSIVE COMPANIES 370
11.6.2 RESPONSIVE COMPANIES 370
11.6.3 DYNAMIC COMPANIES 370
11.6.4 STARTING BLOCKS 370
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 372
11.6.5.1 Detailed list of key startup/SME players 372
11.6.5.2 Competitive benchmarking of key emerging players/startups 373
11.7 COMPANY VALUATION & FINANCIAL METRICS 373
11.7.1 FINANCIAL METRICS 373
11.7.2 COMPANY VALUATION 374
11.8 BRAND/PRODUCT COMPARISON 375
11.9 COMPETITIVE SCENARIO 376
11.9.1 PRODUCT LAUNCHES & APPROVALS 376
11.9.2 DEALS 377
11.9.3 OTHER DEVELOPMENTS 377
12 COMPANY PROFILES 378
12.1 KEY PLAYERS 378
12.1.1 BECTON, DICKINSON AND COMPANY 378
12.1.1.1 Business overview 378
12.1.1.2 Products offered 379
12.1.1.3 Recent developments 384
12.1.1.3.1 Deals 384
12.1.1.4 MnM view 385
12.1.1.4.1 Key strengths 385
12.1.1.4.2 Strategic choices 385
12.1.1.4.3 Weaknesses & competitive threats 385
12.1.2 TELEFLEX INCORPORATED 386
12.1.2.1 Business overview 386
12.1.2.2 Products offered 387
12.1.2.3 Recent developments 390
12.1.2.3.1 Product launches 390
12.1.2.3.2 Other developments 391
12.1.2.4 MnM view 391
12.1.2.4.1 Key strengths 391
12.1.2.4.2 Strategic choices 391
12.1.2.4.3 Weaknesses & competitive threats 391
12.1.3 ICU MEDICAL 392
12.1.3.1 Business overview 392
12.1.3.2 Products offered 393
12.1.3.3 Recent developments 396
12.1.3.3.1 Deals 396
12.1.3.4 MnM view 396
12.1.3.4.1 Key strengths 396
12.1.3.4.2 Strategic choices 396
12.1.3.4.3 Weaknesses & competitive threats 396
12.1.4 NIPRO 397
12.1.4.1 Business overview 397
12.1.4.2 Products offered 398
12.1.4.3 MnM view 399
12.1.4.3.1 Key strengths 399
12.1.4.3.2 Strategic choices 399
12.1.4.3.3 Weaknesses & competitive threats 399
12.1.5 ANGIODYNAMICS, INC. 400
12.1.5.1 Business overview 400
12.1.5.2 Products offered 401
12.1.5.3 Recent developments 402
12.1.5.3.1 Product approvals 402
12.1.5.3.2 Deals 402
12.1.5.4 MnM view 403
12.1.5.4.1 Key strengths 403
12.1.5.4.2 Strategic choices 403
12.1.5.4.3 Weaknesses & competitive threats 403
12.1.6 VYGON 404
12.1.6.1 Business overview 404
12.1.6.2 Products offered 404
12.1.7 TERUMO CORPORATION 411
12.1.7.1 Business overview 411
12.1.7.2 Products offered 413
12.1.8 MEDTRONIC PLC 414
12.1.8.1 Business overview 414
12.1.8.2 Products offered 415
12.1.9 COOK 417
12.1.9.1 Business overview 417
12.1.9.2 Products offered 417
12.1.10 B. BRAUN SE 419
12.1.10.1 Business overview 419
12.1.10.2 Products offered 420
12.1.10.3 Recent developments 425
12.1.10.3.1 Product launches & approvals 425
12.1.10.3.2 Deals 426
12.1.11 MERIT MEDICAL SYSTEMS, INC. 427
12.1.11.1 Business overview 427
12.1.11.2 Products offered 428
12.1.11.3 Recent developments 429
12.1.11.3.1 Deals 429
12.1.12 AMECATH 430
12.1.12.1 Business overview 430
12.1.12.2 Products offered 430
12.1.13 MEDICAL COMPONENTS, INC. 433
12.1.13.1 Business overview 433
12.1.13.2 Products offered 433
12.1.14 HEALTHLINE MEDICAL PRODUCTS 436
12.1.14.1 Business overview 436
12.1.14.2 Products offered 436
12.1.15 ACCESS VASCULAR, INC. 438
12.1.15.1 Business overview 438
12.1.15.2 Products offered 438
?
12.2 OTHER PLAYERS 439
12.2.1 ARGON MEDICAL DEVICES 439
12.2.2 PAKUMEDMEDICAL PRODUCTS GMBH 440
12.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD. 441
12.2.4 PFM MEDICAL GMBH 442
12.2.5 MEDI-TECH DEVICES PVT. LTD. 443
12.2.6 KIMAL 444
12.2.7 POLYMEDICURE 445
12.2.8 DELTAMED 446
12.2.9 NEWTECH MEDICAL DEVICES PVT. LTD. 447
12.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD. 448
13 APPENDIX 449
13.1 DISCUSSION GUIDE 449
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 457
13.3 CUSTOMIZATION OPTIONS 459
13.4 RELATED REPORTS 459
13.5 AUTHOR DETAILS 460

List of Figures

IGURE 1 VASCULAR ACCESS DEVICES MARKET: SEGMENTS
CONSIDERED & GEOGRAPHICAL SPREAD 42
FIGURE 2 VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED 44
FIGURE 3 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN 46
FIGURE 4 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 48
FIGURE 5 VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES 49
FIGURE 6 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 50
FIGURE 7 VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 51
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 51
FIGURE 9 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 52
FIGURE 10 VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH 53
FIGURE 11 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS 54
FIGURE 12 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET 55
FIGURE 13 VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS 55
FIGURE 14 VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION 57
FIGURE 15 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD 60
FIGURE 16 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030 61
FIGURE 17 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD 61
FIGURE 18 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 62
FIGURE 19 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD 63
FIGURE 20 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE
FROM 2024 TO 2030 63
FIGURE 21 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN
APPLICATIONS SEGMENT 64
FIGURE 22 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD 65
FIGURE 23 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE
DURING FORECAST PERIOD 65
FIGURE 24 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD 66
FIGURE 25 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR
VASCULAR ACCESS DEVICES 67
FIGURE 26 RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET 68
FIGURE 27 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023 69
FIGURE 28 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 70
FIGURE 29 ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030 71
FIGURE 30 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING STUDY PERIOD 71
FIGURE 31 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 72
FIGURE 32 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS 80
FIGURE 33 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS 80
FIGURE 34 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS 83
FIGURE 35 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 86
FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 88
FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES 89
FIGURE 38 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024) 94
FIGURE 39 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014?DECEMBER 2024) 95
FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES
(JANUARY 2014? DECEMBER 2024) 96
FIGURE 41 VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW 99
FIGURE 42 VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 101
FIGURE 43 VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS 2019–2023 101
FIGURE 44 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI 103
FIGURE 45 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT 175
FIGURE 46 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 179
FIGURE 47 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 253
FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS
DEVICES MARKET (2019–2023) 360
FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS
DEVICES MARKET (2023) 361
FIGURE 50 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 363
FIGURE 51 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT 364
FIGURE 52 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 371
FIGURE 53 EV/EBITDA OF KEY VENDORS 373
FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 374
FIGURE 55 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 375
FIGURE 56 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 379
FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 387
FIGURE 58 ICU MEDICAL: COMPANY SNAPSHOT 393
FIGURE 59 NIPRO: COMPANY SNAPSHOT 398
FIGURE 60 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT 401
FIGURE 61 TERUMO CORPORATION: COMPANY SNAPSHOT 412
FIGURE 62 MEDTRONIC PLC: COMPANY SNAPSHOT 415
FIGURE 63 B. BRAUN SE: COMPANY SNAPSHOT 420
FIGURE 64 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 428

List of Tables

TABLE 1 VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS 43
TABLE 2 STANDARD CURRENCY CONVERSION RATES 44
TABLE 3 VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS 58
TABLE 4 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS 59
TABLE 5 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM 81
TABLE 6 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION) 84
TABLE 7 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION) 85
TABLE 8 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES 85
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 88
TABLE 10 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES 89
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 90
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 90
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 91
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 91
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 92
TABLE 16 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES BY KEY PLAYER, 2021–2023 97
TABLE 17 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES BY REGION, 2021–2023 97
TABLE 18 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 98
TABLE 19 VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 100
TABLE 20 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 105
TABLE 21 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 105
TABLE 22 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 106
TABLE 23 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 106
TABLE 24 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 107
TABLE 25 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 108
TABLE 26 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 109
TABLE 27 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY 2024–2030 (USD MILLION) 110
TABLE 28 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 111
TABLE 29 TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 112
TABLE 30 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 113
TABLE 31 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 114
TABLE 32 IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 115
TABLE 33 IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 115
TABLE 34 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 116
TABLE 35 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 117
TABLE 36 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 118
TABLE 37 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY 2024–2030 (USD MILLION) 119
TABLE 38 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 120
TABLE 39 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY 2024–2030 (USD MILLION) 121
TABLE 40 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 122
TABLE 41 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 122
TABLE 42 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 123
TABLE 43 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 124
TABLE 44 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 125
TABLE 45 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 125
TABLE 46 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 126
TABLE 47 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 127
TABLE 48 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 128
TABLE 49 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY 2024–2030 (USD MILLION) 129
TABLE 50 MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 130
TABLE 51 MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 131
TABLE 52 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 132
TABLE 53 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 133
TABLE 54 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 134
TABLE 55 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 135
TABLE 56 ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 136
TABLE 57 ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 137
TABLE 58 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 138
TABLE 59 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 139
TABLE 60 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 141
TABLE 61 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 141
TABLE 62 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION) 142
TABLE 63 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION) 143
TABLE 64 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION) 144
TABLE 65 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION) 145
TABLE 66 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION) 146
TABLE 67 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION) 147
TABLE 68 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 149
TABLE 69 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 149
TABLE 70 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 150
TABLE 71 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 150
TABLE 72 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION) 151
TABLE 73 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION) 152
TABLE 74 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY 2021–2023 (USD MILLION) 153
TABLE 75 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY 2024–2030 (USD MILLION) 154
TABLE 76 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION BY COUNTRY, 2021–2023 (USD MILLION) 155
TABLE 77 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION BY COUNTRY, 2024–2030 (USD MILLION) 156
TABLE 78 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION) 157
TABLE 79 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION) 158
TABLE 80 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION) 159
TABLE 81 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION) 160
TABLE 82 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION) 161
TABLE 83 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION) 162
TABLE 84 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 164
TABLE 85 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 164
TABLE 86 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 165
TABLE 87 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 165
TABLE 88 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 166
TABLE 89 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 167
TABLE 90 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 168
TABLE 91 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 169
TABLE 92 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION) 170
TABLE 93 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION) 171
TABLE 94 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION) 172
TABLE 95 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION) 173
TABLE 96 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 176
TABLE 97 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 177
TABLE 98 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS) 178
TABLE 99 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 179
TABLE 100 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 180
TABLE 101 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 180
TABLE 102 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 180
TABLE 103 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 181
TABLE 104 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 181
TABLE 105 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE 2021–2023 (USD MILLION) 181
TABLE 106 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE 2024–2030 (USD MILLION) 182
TABLE 107 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 182
TABLE 108 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 182
TABLE 109 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 183
TABLE 110 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 183
TABLE 111 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION) 183
TABLE 112 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION) 184
TABLE 113 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 184
TABLE 114 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 184
TABLE 115 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 185
TABLE 116 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 185
TABLE 117 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 185
TABLE 118 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 186
TABLE 119 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION) 186
TABLE 120 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION) 186
TABLE 121 US: KEY MACROINDICATORS 187
TABLE 122 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 187
TABLE 123 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 188
TABLE 124 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 188
TABLE 125 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,
2024–2030 (USD MILLION) 188
TABLE 126 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 189
TABLE 127 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 189
TABLE 128 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 189
TABLE 129 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 190
TABLE 130 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 190
TABLE 131 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 190
TABLE 132 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 191
TABLE 133 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 191
TABLE 134 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 191
TABLE 135 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 192
TABLE 136 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 192
TABLE 137 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 192
TABLE 138 US: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 193
TABLE 139 US: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 193
TABLE 140 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 193
TABLE 141 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 194
TABLE 142 CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024 194
TABLE 143 CANADA: KEY MACROINDICATORS 195
TABLE 144 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 195
TABLE 145 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 195
TABLE 146 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 196
TABLE 147 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 196
TABLE 148 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 196
TABLE 149 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 197
TABLE 150 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 197
TABLE 151 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 197
TABLE 152 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 198
TABLE 153 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 198
TABLE 154 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 198
TABLE 155 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 199
TABLE 156 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 199
TABLE 157 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 199
TABLE 158 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2021–2023 (USD MILLION) 200
TABLE 159 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2024–2030 (USD MILLION) 200
TABLE 160 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 200
TABLE 161 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 201
TABLE 162 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 201
TABLE 163 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 201
TABLE 164 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2021–2023 (USD MILLION) 202
TABLE 165 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION) 203
TABLE 166 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 203
TABLE 167 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 203
TABLE 168 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 204
TABLE 169 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 204
TABLE 170 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 204
TABLE 171 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 205
TABLE 172 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 205
TABLE 173 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 205
TABLE 174 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 206
TABLE 175 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 206
TABLE 176 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 206
TABLE 177 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 207
TABLE 178 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 207
TABLE 179 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 207
TABLE 180 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2021–2023 (USD MILLION) 208
TABLE 181 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2024–2030 (USD MILLION) 208
TABLE 182 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 208
TABLE 183 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 209
TABLE 184 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 209
TABLE 185 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 209
TABLE 186 GERMANY: KEY MACROINDICATORS 210
TABLE 187 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 210
TABLE 188 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 211
TABLE 189 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 211
TABLE 190 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 211
TABLE 191 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 212
TABLE 192 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 212
TABLE 193 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 212
TABLE 194 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 212
TABLE 195 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 213
TABLE 196 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 213
TABLE 197 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION) 213
TABLE 198 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION) 214
TABLE 199 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 214
TABLE 200 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 214
TABLE 201 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2021–2023 (USD MILLION) 215
TABLE 202 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2024–2030 (USD MILLION) 215
TABLE 203 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 215
TABLE 204 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 216
TABLE 205 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION) 216
TABLE 206 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION) 216
TABLE 207 UK: KEY MACROINDICATORS 217
TABLE 208 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 217
TABLE 209 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 218
TABLE 210 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 218
TABLE 211 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 218
TABLE 212 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 219
TABLE 213 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 219
TABLE 214 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 219
TABLE 215 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 219
TABLE 216 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 220
TABLE 217 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 220
TABLE 218 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 220
TABLE 219 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 221
TABLE 220 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 221
TABLE 221 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 221
TABLE 222 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 222
TABLE 223 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 222
TABLE 224 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 222
TABLE 225 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 223
TABLE 226 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 223
TABLE 227 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 223
TABLE 228 FRANCE: KEY MACROINDICATORS 224
TABLE 229 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 224
TABLE 230 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 225
TABLE 231 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 225
TABLE 232 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 225
TABLE 233 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 226
TABLE 234 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 226
TABLE 235 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 226
TABLE 236 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 226
TABLE 237 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 227
TABLE 238 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 227
TABLE 239 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 227
TABLE 240 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 228
TABLE 241 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 228
TABLE 242 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 228
TABLE 243 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2021–2023 (USD MILLION) 229
TABLE 244 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2024–2030 (USD MILLION) 229
TABLE 245 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 229
TABLE 246 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 230
TABLE 247 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 230
TABLE 248 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 230
TABLE 249 ITALY: KEY MACROINDICATORS 231
TABLE 250 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 231
TABLE 251 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 232
TABLE 252 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 232
TABLE 253 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 232
TABLE 254 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 233
TABLE 255 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 233
TABLE 256 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 233
TABLE 257 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 233
TABLE 258 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 234
TABLE 259 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 234
TABLE 260 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2021–2023 (USD MILLION) 234
TABLE 261 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION 2024–2030 (USD MILLION) 235
TABLE 262 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2021–2023 (USD MILLION) 235
TABLE 263 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 2024–2030 (USD MILLION) 235
TABLE 264 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2021–2023 (USD MILLION) 236
TABLE 265 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION BY TYPE, 2024–2030 (USD MILLION) 236
TABLE 266 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER 2021–2023 (USD MILLION) 236
TABLE 267 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER 2024–2030 (USD MILLION) 237
TABLE 268 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2021–2023 (USD MILLION) 237
TABLE 269 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE 2024–2030 (USD MILLION) 237
TABLE 270 SPAIN: KEY MACROINDICATORS 238
TABLE 271 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 238
TABLE 272 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 239
TABLE 273 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 239
TABLE 274 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE 2024–2030 (USD MILLION) 239
TABLE 275 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 240
TABLE 276 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION) 240
TABLE 277 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 2021–2023 (USD MILLION) 240
TABLE